Drug class
Antidepressants Alpha-2 Receptor Antagonists
Alpha-2 receptor antagonist antidepressants, also commonly referred to in clinical literature as noradrenergic and specific serotonergic antidepressants (NaSSAs) or tetracyclic antidepressants like mirtazapine, are psychotropic agents used primarily in psychiatry. Read more about Antidepressants Alpha-2 Receptor Antagonists
28 drugs in this class 25 manufacturers
Drugs in Antidepressants Alpha-2 Receptor Antagonists
REMERON (mirtazapine)
REMERON SOLTAB (mirtazapine)
MIRTAZAPINE
MIRTAZAPINE
MIRTAZAPINE
MIRTAZAPINE
MIRTAZAPINE
MIRTAZAPINE
Alpha-2 receptor antagonist antidepressants, also commonly referred to in clinical literature as noradrenergic and specific serotonergic antidepressants (NaSSAs) or tetracyclic antidepressants like mirtazapine, are psychotropic agents used primarily in psychiatry.
Their principal mechanism involves blocking central presynaptic alpha-2 adrenergic autoreceptors and heteroreceptors, thereby interrupting negative feedback loops and enhancing the synaptic release of both norepinephrine and serotonin.
They frequently display concurrent antagonist actions at postsynaptic serotonin 5-HT2 and 5-HT3 receptors, as well as histamine H1 receptors, contributing to sedative and appetite-stimulating effects.
Clinically, these agents are primarily indicated for major depressive disorder and are routinely used to manage depression characterized by insomnia, weight loss, or comorbid anxiety symptoms.
-
nih.gov
Alpha-2 receptor antagonist antidepressants, also commonly referred to in clinical literature as noradrenergic and specific serotonergic antidepressants (NaSSAs) or tetracyclic antidepressants like mirtazapine, are psychotropic agents used primarily in psychiatry Their principal mechanism involves blocking central presynaptic alpha-2 adrenergic autoreceptors and heteroreceptors, thereby interrupting negative feedback loops and enhancing the synaptic release of both norepinephrine and serotonin T...
-
nih.gov
Their principal mechanism involves blocking central presynaptic alpha-2 adrenergic autoreceptors and heteroreceptors, thereby interrupting negative feedback loops and enhancing the synaptic release of both norepinephrine and serotonin
-
rxlist.com
They frequently display concurrent antagonist actions at postsynaptic serotonin 5-HT2 and 5-HT3 receptors, as well as histamine H1 receptors, contributing to sedative and appetite-stimulating effects
-
nih.gov
Clinically, these agents are primarily indicated for major depressive disorder and are routinely used to manage depression characterized by insomnia, weight loss, or comorbid anxiety symptoms
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.